Hyperuricemia is associated with an excess of urate in the blood, which can lead to #kidneystones and the formation of needlelike crystals in the joints. Learn more about #hyperuricemia here: bit.ly/3uxp1qf

In September, the National Kidney Foundation and American Society of Nephrology Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases released a report outlining a new method to diagnose #kidneydisease and advance #healthequity. Learn more: bit.ly/3ou5x4L

In enteric #hyperoxaluria, the absorption of too much oxalate from foods due to an underlying malabsorptive gastrointestinal condition can lead to the formation of #kidneystones and other complications. Learn more: bit.ly/3B4bSax

We are proud to join Oxalosis & Hyperoxaluria Foundation in recognizing #HyperoxaluriaWeek2021! Community activities throughout the week will put a spotlight on challenges in #hyperoxaluria and the importance of early diagnosis. Learn how to participate here: bit.ly/2Ygh793 #RaiseTheHype2021

We recently announced Allena received Fast Track designation from the U.S. FDA for a treatment of hyperuricemia in gout patients with advanced chronic kidney disease. For details, see our press release: bit.ly/2ZRQS96 #KidneyWk #kidneydisease #CKD

In this interview with Urology Times, expert endourologist Dr. Kyle Wood of UAB describes the diagnostic processes of enteric hyperoxaluria, as well as common challenges faced in reaching a diagnosis: bit.ly/38zz443 #HyperoxaluriaWeek2021 #RaiseTheHype2021 Oxalosis & Hyperoxaluria Foundation

This #HyperoxaluriaWeek2021, Oxalosis & Hyperoxaluria Foundation is providing members of the #hyperoxaluria community a special opportunity to share their diagnosis stories. Learn more: bit.ly/3weONAv #RaiseTheHype2021

In enteric #hyperoxaluria, an underlying malabsorptive GI condition leads to absorption of too much oxalate from foods. Too much oxalate in the urine may cause inflammation or #kidneystones. Learn more: bit.ly/3uxp1qf #HyperoxaluriaWeek2021 #RaiseTheHype2021 Oxalosis & Hyperoxaluria Foundation

Stories from the #hyperoxaluria community continue to inspire our team at Allena. Watch Oxalosis & Hyperoxaluria Foundation’s Faces of Hyperoxaluria video to hear stories from individuals and families affected by hyperoxaluria: bit.ly/3nU7DsV #HyperoxaluriaWeek2021 #RaiseTheHype2021

Although #HyperoxaluriaWeek2021 has come to an end, there is still work to be done to ensure all members of the #hyperoxaluria community receive the support they need. Thank you to Oxalosis & Hyperoxaluria Foundation for creating a platform to bring hope to patients and families. bit.ly/2Ygh793

Interested in learning more about our research in enteric #hyperoxaluria? See our publications here: bit.ly/3D3M9Qd

The most common type of kidney stones are calcium stones, which are caused by a substance called calcium oxalate. For some people, these types of stones are the result of a condition called enteric #hyperoxaluria. Learn more about enteric hyperoxaluria: bit.ly/3B4bSax

#ICYMI In November, our leadership team presented a corporate overview at the Stifel 2021 Virtual Healthcare Conference. Access a webcast recording of the presentation here: bit.ly/3y3uPts

In this video, expert endourologist Dr. Kyle Wood of UAB reviews data and clinical implications from the Phase 3 URIROX trial in enteric #hyperoxaluria: bit.ly/31E2f5t

During American Society of Nephrology’s Annual Meeting & Scientific Exposition, National Kidney Foundation presented the NKF Patient Network, a program created to help people living with #kidneydisease access important updates on clinical research. Learn more: bit.ly/3do4nBd

Hyperuricemia is associated with an excess of urate in the blood, which can lead to #kidneystones and the formation of needlelike crystals in the joints. Learn more about #hyperuricemia here: bit.ly/3uxp1qf

In enteric #hyperoxaluria, the absorption of too much oxalate from foods due to an underlying malabsorptive gastrointestinal condition can lead to the formation of #kidneystones and other complications. Learn more: bit.ly/3B4bSax

Please join us for Allena Pharmaceuticals KOL Event to Review Topline ALLN- 346 Phase 2a Data featuring Key Opinion Leaders Robert Terkeltaub, M.D. (UC San Diego) and David S. Goldfarb, M.D. (NYU Langone). A live Q&A session will follow. Register here: lifesci.events/ALNA2

Today we shared progress updates on our clinical development programs in #hyperuricemia and #gout in the setting of chronic kidney disease as well as enteric #hyperoxaluria, and a corporate update. For details, see our press release: ir.allenapharma.com/news-releases/…

Today we shared progress updates on our clinical development program in #hyperuricemia and #gout in the setting of chronic kidney disease ir.allenapharma.com/news-releases/…